Johnson & Johnson
JNJ
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGXā¦ read more
Healthcare
Drug Manufacturers - General
81 years
USD
85
/100
Price
per share adjusted in USD$186.60
Price-0.17%
-$0.33
1Y
Price
Market Cap
$449.574b
Large
Price/Earnings
18x
17.5x
3y Avg19.6x
5y AvgFinancials Overview
Key metrics over the past few years+27.3%
EBITDA Margin+23.3%
Net Profit Margin+10.5%
Free Cash Flow MarginRevenue
$90.627b
+2.0%
1y CAGR+4.3%
3y CAGR+3.6%
5y CAGREarnings
$22.661b
+61.1%
1y CAGR+32.4%
3y CAGR+20.7%
5y CAGREPS
$9.35
+61.5%
1y CAGR+35.9%
3y CAGR+23.4%
5y CAGRBook Value
$78.473b
$193.389b
Assets$114.916b
Liabilities$50.761b
DebtDebt to Assets
26.3%
1.5x
Debt to EBITDAFree Cash Flow
$16.397b
-17.4%
1y CAGR-0.8%
3y CAGR-3.9%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company